Oncogene rearrangements in chronic B-cell leukemia

Area of Science:

• Hematology
• Molecular Biology
• Oncology

Background:

• B-chronic lymphocytic leukemia (CLL) is a heterogeneous B-cell malignancy.
• Understanding genetic alterations is crucial for classifying CLL subtypes and guiding treatment.
• Previous studies suggested the involvement of specific gene loci in CLL pathogenesis.

Purpose of the Study:

• To investigate genetic rearrangements in key oncogenes and tumor suppressor genes in a cohort of B-CLL patients.
• To correlate specific genetic alterations with clinical features, such as CD5 expression.
• To further elucidate the molecular basis of CLL heterogeneity.

Main Methods:

• Southern blot analysis was performed on DNA from 44 B-CLL cases.
• Probes were used to detect rearrangements in Ig genes, bcl-1, bcl-2 (major, minor, 5' breakpoint region), bcl-3, c-myc, and retinoblastoma (Rb) loci.
• Chromosomal translocations were identified by comigration of rearranged gene sequences and JH bands.

Main Results:

• Eight cases exhibited oligoclonality or clonal evolution indicated by multiple rearranged JH bands.
• One case showed a t(11;14)(q13;q32) translocation involving bcl-1.
• Three cases displayed bcl-2 rearrangements, including one with a t(14;18)(q32;q21) translocation. Rearrangements at the bcl-2 5' breakpoint region were confirmed. No c-myc, bcl-3, or Rb alterations were detected. CD5 expression was absent in the t(11;14) and t(14;18) cases.

Conclusions:

• The study confirms the presence of bcl-2 rearrangements in CLL and identifies specific translocations like t(11;14) and t(14;18).
• The findings support the classification of CD5-negative B-cell leukemias as distinct entities from classical CLL.
• Genetic profiling provides valuable insights into the molecular heterogeneity of B-cell chronic lymphocytic leukemia.